Description: Elixinol Global Limited is an Australia-based company. The Company owns and operates hemp and medicinal cannabis industries. The Company is focused on developing, manufacturing and distributing industrial hemp products and early stage medical cannabis business.
Home Page: www.elixinolwellness.com
EXL Technical Analysis
680 George Street
Sydney,
NSW
2000
Australia
Phone:
61 2 4044 4585
Officers
| Name | Title |
|---|---|
| Mr. Ronald Dufficy BEC, FCPA | Interim Global Chief Exec. Officer |
| Ms. Josephine Lorenz | Global CFO & Group Financial Controller |
| Glen Zurcher | Account Director of Investor Relations Department |
| Ms. Teresa Cleary | Gen. Counsel & Company Sec. |
| Mr. Rob Hasselman | Pres of Americas |
| Ms. Beata Silber | Global Head of R&D and Innovation |
| Ms. Kim Bradley-Ware | Joint Company Sec. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.5837 |
| Price-to-Sales TTM: | 0.8147 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |